Wen-I Chang

1.3k total citations
9 papers, 112 citations indexed

About

Wen-I Chang is a scholar working on Molecular Biology, Neurology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Wen-I Chang has authored 9 papers receiving a total of 112 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 3 papers in Neurology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Wen-I Chang's work include Protein Degradation and Inhibitors (7 papers), Histone Deacetylase Inhibitors Research (4 papers) and Sarcoma Diagnosis and Treatment (2 papers). Wen-I Chang is often cited by papers focused on Protein Degradation and Inhibitors (7 papers), Histone Deacetylase Inhibitors Research (4 papers) and Sarcoma Diagnosis and Treatment (2 papers). Wen-I Chang collaborates with scholars based in United States and Poland. Wen-I Chang's co-authors include Joanna Szmydynger‐Chodobska, J. Frederick Harrington, Adam Chodobski, In‐Sung Chung, John A. Duncan, Ewa Koźniewska, Wafik S. El‐Deiry, Nikos Tapinos, Lanlan Zhou and Aditi Sharma and has published in prestigious journals such as Blood, Cancer Research and Neuroscience.

In The Last Decade

Wen-I Chang

9 papers receiving 112 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wen-I Chang United States	5	60	45	17	17	14	9	112
Claire Borie France	6	49 0.8×	45 1.0×	13 0.8×	38 2.2×	4 0.3×	12	167
Camille K. Hunt United Kingdom	3	48 0.8×	29 0.6×	7 0.4×	14 0.8×	3 0.2×	4	94
Yiyao Cao China	7	84 1.4×	18 0.4×	21 1.2×	20 1.2×	27 1.9×	12	130
Andreea Ilinca Sweden	8	61 1.0×	87 1.9×	14 0.8×	21 1.2×	3 0.2×	17	181
Séan Lyne United States	7	33 0.6×	78 1.7×	6 0.4×	7 0.4×	5 0.4×	17	150
Eman Bakhsh Saudi Arabia	6	245 4.1×	16 0.4×	13 0.8×	15 0.9×	10 0.7×	9	299
J.A. García-Merino Spain	7	39 0.7×	33 0.7×	15 0.9×	14 0.8×	14 1.0×	12	126
Neza Alfazema United Kingdom	8	170 2.8×	36 0.8×	10 0.6×	8 0.5×	28 2.0×	10	257
Jaromíra Kovářová Australia	6	150 2.5×	49 1.1×	27 1.6×	20 1.2×	11 0.8×	10	234

Countries citing papers authored by Wen-I Chang

Since Specialization

Citations

This map shows the geographic impact of Wen-I Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wen-I Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wen-I Chang more than expected).

Fields of papers citing papers by Wen-I Chang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wen-I Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wen-I Chang. The network helps show where Wen-I Chang may publish in the future.

Co-authorship network of co-authors of Wen-I Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Wen-I Chang. A scholar is included among the top collaborators of Wen-I Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wen-I Chang. Wen-I Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Chang, Wen-I, Joshua N. Honeyman, Aditi Sharma, et al.. (2023). Novel combination of imipridones and histone deacetylase inhibitors demonstrate cytotoxic effect through integrated stress response in pediatric solid tumors.. PubMed. 13(12). 6241–6255. 4 indexed citations

Chang, Wen-I, et al.. (2022). Molecular Targets for Novel Therapeutics in Pediatric Fusion-Positive Non-CNS Solid Tumors. Frontiers in Pharmacology. 12. 747895–747895. 9 indexed citations

Miller, Lane R., Stephanie Massaro, Robin Williams, et al.. (2022). Anti-Leukemic Activity of STRO-002 a Novel Folate Receptor-α (FR-α)-Targeting ADC in Relapsed/Refractory CBF2AT3-GLIS2 AML. Blood. 140(Supplement 1). 159–161. 2 indexed citations

Zhou, Lanlan, Wen-I Chang, Yiqun Zhang, et al.. (2021). Potent preclinical sensitivity to imipridone-based combination therapies in oncohistone H3K27M-mutant diffuse intrinsic pontine glioma is associated with induction of the integrated stress response, TRAIL death receptor DR5, reduced ClpX and apoptosis.. PubMed. 11(9). 4607–4623. 12 indexed citations

Honeyman, Joshua N., Wen-I Chang, Varun V. Prabhu, et al.. (2021). Abstract 1040: Imipridones exhibit synergy with sorafenib, HDAC inhibition, PARP inhibition, and proteasome inhibition in liver cancer cell lines. Cancer Research. 81(13_Supplement). 1040–1040. 1 indexed citations

Chang, Wen-I, Lanlan Zhou, Attila A. Seyhan, Varun V. Prabhu, & Wafik S. El‐Deiry. (2021). Abstract 1060: Combinatorial therapy of imipridones and histone deacetylase inhibitors in Ewing sarcoma cell lines demonstrates synergistic cell death. Cancer Research. 81(13_Supplement). 1060–1060. 1 indexed citations

Chang, Wen-I, Lanlan Zhou, Attila A. Seyhan, Yiqun Zhang, & Wafik S. El‐Deiry. (2020). Abstract 3902: Novel therapeutic targeting of epigenetic aberrations in pediatric sarcomas through combination of ONC201 and HDAC inhibitors. Cancer Research. 80(16_Supplement). 3902–3902. 2 indexed citations

Chodobski, Adam, In‐Sung Chung, Ewa Koźniewska, et al.. (2003). Early neutrophilic expression of vascular endothelial growth factor after traumatic brain injury. Neuroscience. 122(4). 853–867. 73 indexed citations

Sun, Lee K., et al.. (1995). Human IgA Monoclonal Antibodies Specific for a Major Ragweed Pollen Antigen. Bio/Technology. 13(8). 779–786. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact